The University of Chicago Header Logo

Connection

Yusuke Nakamura to Binding Sites

This is a "connection" page, showing publications Yusuke Nakamura has written about Binding Sites.
Connection Strength

0.416
  1. The DNA binding site specificity and antiproliferative property of ternary Pt(II) and Zn(II) complexes of phenanthroline and N,N'-ethylenediaminediacetic acid. Dalton Trans. 2013 Mar 14; 42(10):3337-45.
    View in: PubMed
    Score: 0.085
  2. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. Cancer Res. 2003 Oct 01; 63(19):6116-20.
    View in: PubMed
    Score: 0.045
  3. Identification of a novel human gene, ZFP91, involved in acute myelogenous leukemia. Int J Oncol. 2003 Jun; 22(6):1217-23.
    View in: PubMed
    Score: 0.044
  4. Cystatin C as a p53-inducible apoptotic mediator that regulates cathepsin L activity. Cancer Sci. 2016 Mar; 107(3):298-306.
    View in: PubMed
    Score: 0.027
  5. The transcription factor Sp3 regulates the expression of a metastasis-related marker of sarcoma, actin filament-associated protein 1-like 1 (AFAP1L1). PLoS One. 2013; 8(1):e49709.
    View in: PubMed
    Score: 0.021
  6. Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells. Nat Commun. 2013; 4:2443.
    View in: PubMed
    Score: 0.021
  7. Quantitative structural characterization of local N-glycan microheterogeneity in therapeutic antibodies by energy-resolved oxonium ion monitoring. Anal Chem. 2012 Nov 20; 84(22):9655-62.
    View in: PubMed
    Score: 0.021
  8. Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma. Am J Respir Cell Mol Biol. 2011 Jun; 44(6):787-93.
    View in: PubMed
    Score: 0.018
  9. Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet. 2010 Jul 15; 19(14):2898-906.
    View in: PubMed
    Score: 0.018
  10. A functional SNP in the NKX2.5-binding site of ITPR3 promoter is associated with susceptibility to systemic lupus erythematosus in Japanese population. J Hum Genet. 2008; 53(2):151-162.
    View in: PubMed
    Score: 0.015
  11. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. Int J Oncol. 2005 Dec; 27(6):1483-7.
    View in: PubMed
    Score: 0.013
  12. Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum Genet. 2005 Jun; 117(1):16-26.
    View in: PubMed
    Score: 0.012
  13. DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene. 2004 Nov 04; 23(52):8520-6.
    View in: PubMed
    Score: 0.012
  14. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet. 2004; 49(3):134-140.
    View in: PubMed
    Score: 0.012
  15. Identification of the interleukin 4 receptor alpha gene as a direct target for p73. Cancer Res. 2003 Dec 01; 63(23):8145-52.
    View in: PubMed
    Score: 0.011
  16. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene. 2002 Aug 29; 21(38):5861-7.
    View in: PubMed
    Score: 0.010
  17. Cyclin K as a direct transcriptional target of the p53 tumor suppressor. Neoplasia. 2002 May-Jun; 4(3):268-74.
    View in: PubMed
    Score: 0.010
  18. Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene. 2002 Apr 25; 21(18):2914-8.
    View in: PubMed
    Score: 0.010
  19. Identification of semaphorin3B as a direct target of p53. Neoplasia. 2002 Jan-Feb; 4(1):82-7.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.